- Home
- GOSS vs VINP Comparison
GOSS vs VINP Comparison
Compare GOSS & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- VINP
- Stock Information
- Founded
- GOSS 2015
- VINP 2009
- Country
- GOSS United States
- VINP Brazil
- Employees
- GOSS N/A
- VINP N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- GOSS Health Care
- VINP Finance
- Exchange
- GOSS Nasdaq
- VINP Nasdaq
- Market Cap
- GOSS 586.6M
- VINP 636.2M
- IPO Year
- GOSS 2019
- VINP 2021
- Fundamental
- Price
- GOSS $3.08
- VINP $10.33
- Analyst Decision
- GOSS Strong Buy
- VINP Strong Buy
- Analyst Count
- GOSS 6
- VINP 2
- Target Price
- GOSS $8.60
- VINP $13.50
- AVG Volume (30 Days)
- GOSS 4.8M
- VINP 38.0K
- Earning Date
- GOSS 11-06-2025
- VINP 11-06-2025
- Dividend Yield
- GOSS N/A
- VINP 6.35%
- EPS Growth
- GOSS N/A
- VINP N/A
- EPS
- GOSS N/A
- VINP 0.50
- Revenue
- GOSS $40,237,000.00
- VINP $153,475,995.00
- Revenue This Year
- GOSS N/A
- VINP $68.12
- Revenue Next Year
- GOSS $34.10
- VINP $14.85
- P/E Ratio
- GOSS N/A
- VINP $20.38
- Revenue Growth
- GOSS N/A
- VINP 76.11
- 52 Week Low
- GOSS $0.66
- VINP $8.66
- 52 Week High
- GOSS $3.60
- VINP $10.99
- Technical
- Relative Strength Index (RSI)
- GOSS 61.72
- VINP 62.79
- Support Level
- GOSS $2.93
- VINP $9.75
- Resistance Level
- GOSS $3.37
- VINP $10.09
- Average True Range (ATR)
- GOSS 0.29
- VINP 0.21
- MACD
- GOSS 0.01
- VINP 0.02
- Stochastic Oscillator
- GOSS 57.55
- VINP 95.24
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.